Cancer Immunotherapy Using Checkpoint Blockade

·2018·DOI
Health Sciences and Innovation
Biomedical Engineering
Cancer Research and Treatment
Cancer Treatment Response Evaluation

Role in the Field

Neutralin Health Sciences and Innovation
Neutralin Biomedical Engineering
Neutralin Cancer Research and Treatment
Neutralin Cancer Treatment Response Evaluation

Abstract

Citations

4,837

Year

2018

PageRank

4.0 / 10

Relative influence (log-scaled)

Related Papers

11 of 11 papers

The Molecular Signatures Database Hallmark Gene Set Collection
·2015·9,339 citations
PD-1 Blockade In Tumors With Mismatch-Repair Deficiency
·2015·7,826 citations
The Blockade Of Immune Checkpoints In Cancer Immunotherapy
·2012·11,288 citations
Safety, Activity, And Immune Correlates Of Anti–PD-1 Antibody In Cancer
·2012·10,804 citations
New Response Evaluation Criteria In Solid Tumours: Revised RECIST Guideline (Version 1.1)
·2009·23,079 citations
Comprehensive Genomic Characterization Defines Human Glioblastoma Genes And Core Pathways
·2008·6,780 citations
Bevacizumab Plus Irinotecan, Fluorouracil, And Leucovorin For Metastatic Colorectal Cancer
·2004·9,673 citations
Use Of Chemotherapy Plus A Monoclonal Antibody Against HER2 For Metastatic Breast Cancer That Overexpresses HER2
·2001·10,162 citations
New Guidelines To Evaluate The Response To Treatment In Solid Tumors
·2000·14,975 citations
Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group
·1982·8,462 citations
Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group.
·1982·6,775 citations